The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Sotrovimab Or Xevudy Market Compare Between 2026 And 2030?
The past period’s expansion was primarily driven by the urgent authorization of COVID-19 monoclonal antibodies, the substantial risk of hospitalization during the early stages of the pandemic, the swift rollout of antibody therapies, the government’s acquisition of antiviral treatments, and the enlargement of infrastructure for infusion-based treatments.
The anticipated expansion during the projected timeframe stems from the advancement of antibody treatments effective against various variants, a heightened emphasis on readiness for forthcoming pandemics, augmented financial commitment to antiviral biological products, the broadened availability of outpatient infusion facilities, and the incorporation of monoclonal antibodies into routine medical guidelines.
Prominent trends for the upcoming period involve the growing application of monoclonal antibody treatments, a sharpened attention on addressing viral infections at their initial stages, the broadening scope of antiviral biologicals designed for specific targets, an increasing prioritization of safeguarding vulnerable patients, and accelerated creation of medicines to combat pandemics.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20383&type=smp
What Primary Drivers Are Shaping The Sotrovimab Or Xevudy Market?
The increasing number of COVID-19 infections is projected to fuel the expansion of the sotrovimab or xevudy market in the future. COVID-19, an illness stemming from the SARS-CoV-2 virus, disseminates via respiratory droplets, leading to symptoms ranging from slight fever to critical respiratory problems. Preventative measures include vaccinations and good hygiene practices. The escalating number of COVID-19 cases can be attributed to elements like novel variants, diminishing immunity, relaxed public health mandates, colder season indoor social events, and inconsistent vaccine distribution. Sotrovimab offers treatment for high-risk COVID-19 patients by neutralizing the virus in its early stages, thereby averting serious consequences such as hospital admission or fatality. For example, data from March 2023, released by the Office for National Statistics, a UK government department for official statistics, indicated that approximately 1.9 million individuals in the UK (2.9% of the population) had COVID at that time. A significant majority (92%) had contracted COVID-19 more than 12 weeks prior, with 69% enduring symptoms for over a year and 41% for over two years. Consequently, the growing incidence of COVID cases is set to propel the growth of the sotrovimab or xevudy market.
Which Segments Define The Sotrovimab Or Xevudy Market Segment Structure?
The sotrovimab or xevudy market covered in this report is segmented –
1) By Indication: COVID-19 Early Treatment, Post-Exposure Prophylaxis
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By End User: Pediatric, Adult, Geriatric
Who Are The Established Players Within The Sotrovimab Or Xevudy Market?
Major companies operating in the sotrovimab or xevudy market are GSK plc, Vir Biotechnology Inc.
Get The Full Sotrovimab Or Xevudy Market Report:
https://www.thebusinessresearchcompany.com/report/sotrovimab-or-xevudy-global-market-report
Which Region Accounts For The Largest Portion Of The Sotrovimab Or Xevudy Market?
North America was the largest region in the sotrovimab or xevudy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sotrovimab or xevudy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Sotrovimab Or Xevudy Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/sotrovimab-or-xevudy-global-market-report
Browse Through More Reports Similar to the Global Sotrovimab Or Xevudy Market 2026, By The Business Research Company
Hypermarkets Market Report 2026
https://www.thebusinessresearchcompany.com/report/hypermarkets-global-market-report
Data Lake Market Report 2026
https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report
Market Research Services Market Report 2026
https://www.thebusinessresearchcompany.com/report/market-research-services-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model